Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences
Open Access
- 1 July 2002
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 106 (3) , 316-325
- https://doi.org/10.1046/j.1365-2567.2002.01429.x
Abstract
In murine systems, the B subunit of Escherichia coli heat-labile enterotoxin (EtxB) is a potent immunomodulator capable of suppressing Th1-mediated autoimmune diseases. This results from its ability to bind cell surface receptors, principally GM1-ganglioside, and as a consequence down-regulate the pathological T helper type 1 (Th1) response. The capacity of EtxB to alter human T-cell responses has not been investigated. Here we show that EtxB, but not the receptor non-binding mutant EtxB (G33D), triggers the release of interleukin (IL)-10, IL-6 and tumour necrosis factor-α (TNF-α) by human monocytes. The production of IL-8, transforming growth factor-β (TGF-β) or IL-12 was not enhanced by EtxB. Indeed, EtxB was shown to inhibit IL-12 secretion in monocytes stimulated with interferon-γ (IFN-γ) and lipopolysaccharide (LPS) by an IL-10-independent mechanism. When EtxB-treated monocytes were used as antigen presenting cells in an allogeneic mixed lymphocyte reaction (MLR), IL-10 and IFN-γ production were increased in comparison to levels seen in cultures stimulated with untreated monocytes; proliferation was unaltered. This modulation of the T-cell response was not only evident in the primary MLR triggered by EtxB-treated monocytes, but also upon restimulation of the responding T cells with fresh untreated monocytes; indicating that presentation by EtxB-treated monocytes leads to altered T-cell differentiation. Sorting experiments showed that IL-10 secreting T cells from the MLR cultures were strong suppressors of T-cell proliferation following their addition into a fresh primary MLR.Keywords
This publication has 41 references indexed in Scilit:
- Escherichia coli heat‐labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cellsArthritis & Rheumatism, 2002
- Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-β-secreting cells and suppressing chemokine expressionInternational Immunology, 2000
- Modulation of B‐cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up‐regulates MHC class II, B7, CD40, CD25 and ICAM‐1Immunology, 1997
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsThe Journal of Experimental Medicine, 1997
- Cross-linking of cell surface ganglioside GM1 induces the selective apoptosis of mature CD+ T lymphocytesInternational Immunology, 1996
- Are CD4+ Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-γ or IL-2 determines their functionInternational Immunology, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- CYTOKINE REGULATION OF THE BALANCE BETWEEN ALLOINDIFFERENT AND ALLOSPECIFIC SUPPRESSOR INDUCTION IN MIXED LYMPHOCYTE CULTURESTransplantation, 1990
- Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigensVaccine, 1988
- Pathogenesis of Experimental Cholera in Infant Rabbits: I. Observations on the Intraintestinal Infection and Experimental Cholera Produced with Cell-Free ProductsThe Journal of Infectious Diseases, 1964